[Updated] While still growing its $30MM-$50MM growth fund, JSCap adds notches to its moneybelt.
Seed to B-round scenario begins to emerge, with pharmacogenetic testing a driver.
Education content and assessment are hot segments that Ingram seems to eye.
[Updated] President Aylward said he believes the market is now coming more in MedCenterDisplay's direction
New Jersey-based engagement and loyalty company says Healthcare may become its sole focus.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: